Azalonum (Cinnarizine, Dimenhydrinate)

Azalonum combines Cinnarizine and Dimenhydrinate for oral use, offering relief from motion sickness and vertigo. This medication is manufactured by Medochemie Ltd. in the EU.

Azalonum is commonly used to alleviate symptoms of motion sickness, such as nausea and dizziness. It may also be used to manage vertigo and other balance disorders. The combination of Cinnarizine and Dimenhydrinate works to reduce inner ear disturbances and improve overall comfort during travel or episodes of vertigo.

Azalonum may cause drowsiness, dry mouth, or blurred vision in some individuals. These effects are generally mild and temporary. Users should avoid driving or operating heavy machinery until they know how the medication affects them.

Azalonum should be used with caution in individuals with certain medical conditions, such as liver or kidney disease. It is important to consult a healthcare provider before starting this medication, especially if you are pregnant, breastfeeding, or taking other medications.

Azalonum may interact with alcohol, sedatives, and other medications that cause drowsiness. It is advisable to avoid alcohol while taking this medication. Always inform your healthcare provider about all the medications you are currently taking to avoid potential interactions.